FIELD: chemistry.
SUBSTANCE: invention relates to organic and medical chemistry and specifically to novel compounds of the class of heterocyclic systems – derivatives of 2-aryl-6-(methylthio)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine, of general formula I, where R=H, R1=phenyl (Ia) – 6-(methylthio)-2-phenyl-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-bromophenyl (1b) – 2-(2-bromophenyl)-6-(methylthio)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-methylphenyl (Ic) – 6-(methylthio)-2-(2-methylphenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-methoxyphenyl (Id) – 6-(methylthio)-2-(2-methoxyphenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=2-nitrophenyl (Ie) – 6-(methylthio)-2-(2-nitrophenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3-bromophenyl (If) – 2-(3-bromophenyl)-6-(methylthio)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3-methylphenyl (Ig) – 6-(methylthio)-2-(3-methylphenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3-methoxyphenyl (Ih) – 6-(methylthio)-2-(3-methoxyphenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=3-nitrophenyl (Ii) – 6-(methylthio)-2-(3-nitrophenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=4-bromophenyl (Ij) – 2-(4-bromophenyl)-6-(methylthio)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=4-methylphenyl (Ik) – 6-(methylthio)-2-(4-methylphenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine; R=H, R1=4-methoxyphenyl (Il) – 6-(methylthio)-2-(4-methoxyphenyl)-4-chloro-2H-pyrazolo[3,4-d]pyrimidine. Invention also relates to a method of producing a compound of formula (I).
EFFECT: obtaining novel heterocyclic compounds having antimicrobial activity.
2 cl, 1 dwg, 13 ex
Title | Year | Author | Number |
---|---|---|---|
1-BENZOYL-SUBSTITUTED-6-(METHYLTHIO)-4-CHLORO-1H-PYRAZOLO[3,4-D]PYRIMIDINES AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2709018C1 |
DERIVATIVES OF 1H-PYRAZOLO [3,4-D] PYRIMIDINE AND METHOD OF THEIR PRODUCTION | 2017 |
|
RU2638928C1 |
SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-7-YL COMPOUNDS AS THE INHIBITORS OF PDE2 | 2015 |
|
RU2659070C9 |
DERIVATIVES OF ARYLSULFONEAMIDE OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION SHOWING ANTIPROTECTIVE, ANTIHYPERTENSION AND VASOSPAMOLYTIC, IN PART, ANTIISCHEMIC ACTION | 1992 |
|
RU2083567C1 |
METHOD OF PRODUCING HALOGEN DERIVATIVES OF AROMATIC AND HETEROAROMATIC COMPOUNDS | 2019 |
|
RU2711558C1 |
BICYCLIC DIHYDROPYRIMIDINECARBOXAMIDE DERIVATIVES AS RHO-KINASE INHIBITORS | 2017 |
|
RU2778478C2 |
COMPOUNDS HAVING INHIBITORY ACTIVITY RELATIVELY TO PDE9A AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2788148C2 |
Authors
Dates
2019-12-12—Published
2019-09-26—Filed